ArticleMethods in enzymology2025
Bioinformatics guided synthesis of natural product cyclic peptides.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Natural products are a fantastic source of bioactive molecules but are generally challenging to discover due to the rediscovery of known molecules and silent (i.e. transcriptionally inactive) biosynthetic gene clusters. A recently developed method to overcome this issue is the synthetic-bioinformatic natural product (syn-BNP) approach. In this approach, bioinformatics programs are used to predict natural product structures from cryptic biosynthetic gene clusters followed by chemical synthesis to access these otherwise challenging to acquire molecules. This enables access to natural products, or closely structurally related derivatives, from silent biosynthetic gene clusters or strains that are currently not culturable for biological activation. While this approach has been employed by a handful of laboratories, the bioinformatics pipeline can be challenging to scale due to the need to interface with multiple programs. Presented here is the development of a bioinformatics pipeline B-LinESS (Biosynthesis Linker: from Enzymes to Structures and Synthons), which enables more scalable identification of predicted structures and synthons for natural products based on the shared presence of certain genes of interest. Additionally, we describe methods to chemically synthesize the predicted cyclic peptide natural products. The chemical synthesis allows scalable access to molecules that can then be tested in a variety of bioactivity assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.